Sign up for our newsletter and get the latest big data news and analysis.

HuBMAP Inaugural Data Release Puts Detailed Anatomical Data about Seven Human Organs at the Service of Scientists, Public

HuBMAP (the Human BioMolecular Atlas Program) has released its inaugural data for use by the scientific community and the general public. Included in this release are detailed, 3D anatomical data and genetic sequences of healthy tissues from seven organ types, at the level of individual cells as well as many bulk tissue data sets. HuBMAP’s ultimate goal is to provide the framework required for scientists to create a 3D atlas of the human body.

3 Reasons to Consider Text Mining

A growing number of life science companies use text mining to gather important insights from vast amounts of published information. The results of mining projects inform a wide range of business activities including drug discovery, drug interactions, clinical trial development, drug safety monitoring and competitive intelligence. Download the new Copyright Clearance Center white paper that covers three of the top reasons to consider implementing text mining for life sciences companies.

insideBIGDATA Guide to Healthcare & Life Sciences

The insideBIGDATA Guide to Healthcare & Life Sciences is a useful new resource directed toward enterprise thought leaders who wish to gain strategic insights into this exciting new area of technology. The guide provides an overview of the utilization of big data technologies as an emerging discipline in healthcare and life sciences. It explores the characteristics of this business strategy and the benefits of leveraging big data technologies within these sectors. It also touches on the challenges and future directions of big data and analytics in the healthcare and life sciences industries.

Optimizing Life Sciences – Deploying IBM Platform Computing

In your world – numbers and data can save lives. Minutes and seconds absolutely matter. Whether engaged in genome sequencing, drug design, product analysis or risk management, life sciences research teams need high-performance technical environments with the ability to process massive amounts of data and support increasingly sophisticated simulations and analyses.

Global CEO Initiative on Alzheimer’s Disease Announces a Big Data Challenge

Challenge to be first in a series to crowdsource Alzheimer’s data for new disease insights .

Leveraging High Quality Data to Discover Drugs

The IP & Science Business of Thomson Reuters has announced a strategic initiative with NuMedii. The companies will leverage high-quality data, knowledge and predictive technologies to identify therapeutic candidates with the greatest probability for clinical success.